The role of radiotherapy in spinal metastases: a surgeon's view
Spinal metastases are not simply a problem of destroying tumour. They also involve protecting the spinal cord, preserving useful movement and helping people live with cancer. As a neurosurgeon, I view radiotherapy through a surgical lens: its value depends on anatomy, stability, neurological function, disease trajectory and the goals agreed with the patient.
Red flags include new leg weakness, difficulty walking, saddle numbness, and loss of bladder or bowel control. Rapidly progressive weakness or paralysis warrants emergency assessment rather than a routine outpatient appointment. In Australia, this usually means presentation to an emergency department, followed by imaging and specialist referral, with dexamethasone considered for suspected malignant spinal cord compression under medical supervision.
Timing is never the sole consideration. Not every painful vertebral lesion needs urgent irradiation, and not every operation should be followed by radiotherapy automatically. Surgery and radiation can be complementary, sequential or alternatives. The central questions are whether the cord is compressed, whether the spine can bear load safely, and whether the tumour is likely to respond.
My purpose is to set out a surgeon's view of how radiation fits into care for spinal metastatic disease, while acknowledging the contributions of radiation oncologists, medical oncologists, physicists and palliative-care colleagues. No single protocol fits every patient. A sound plan aligns local treatment with systemic disease, functional goals and the burden of attending appointments.
When the spinal cord is under threat
Spinal metastatic disease should be considered when a patient with cancer develops back or neck pain, limb weakness, sensory change or impaired bladder and bowel function. MRI of the symptomatic region is usually first for suspected cord compression; whole-spine MRI may reveal additional levels that alter the plan. Review by a spinal oncology team should not wait until neurological deterioration is established.
Dexamethasone reduces swelling around the spinal cord and is commonly used in confirmed or strongly suspected malignant spinal cord compression. It cannot substitute for decompression or stabilisation. If the spine remains mechanically stable and the tumour is radiation-sensitive, definitive external beam radiotherapy may be appropriate. Delay can compromise recovery when compression is severe, but treatment must fit the person's overall condition and goals.
Radioresistant primaries, including renal cell carcinoma and melanoma, deserve particular scrutiny. Their vertebral metastases may respond poorly to conventional radiation, strengthening the case for surgical decompression, stabilisation or a combined strategy. Radioresistance does not automatically mandate surgery: tumour volume, systemic disease, symptoms and prior treatment still shape the decision.
What radiotherapy can and cannot achieve
Conventional external beam radiotherapy remains standard for many painful bone metastases and nonsurgical metastatic spinal cord compression. Its aims are pain relief, prevention of local progression and, in selected cases, neurological improvement. Fractionation varies with the clinical goal, nearby tissues at risk and prior irradiation. Longer schedules are not automatically better, and fewer visits may be valuable for a frail patient with difficult travel.
Stereotactic body radiotherapy, often called SBRT, uses image guidance to deliver a precise high dose to a selected vertebral metastasis. It can achieve strong local control while limiting dose to the spinal cord, cauda equina and other organs. Evidence is less mature than for conventional palliative schedules, so multidisciplinary review and careful follow-up remain important. SBRT cannot fix an unstable spine.
Radiation sensitivity differs by tumour biology. Prostate and breast cancer may respond well, while renal cell carcinoma and melanoma can behave differently. Prior radiation, large epidural disease and mechanical collapse complicate dose delivery and prognosis. Re-irradiation is possible in selected patients, but cumulative dose, cord tolerance, vertebral fracture risk and expected benefit must be weighed together.
The surgical decision before treatment begins
The surgical question is often stability. Vertebral body collapse, progressive kyphosis, disruption of the posterior elements, or pain suggesting movement at an affected level raises concern that the spine may fail under load. In the NOMS framework, neurological, oncological, mechanical and systemic factors are considered together. A visible lesion should not be treated as though every problem could be solved by radiation alone.
Operation may provide decompression, stabilisation or correction of deformity. It can also secure a diagnosis when imaging and history leave the cause uncertain. The goal is to protect neurological function and create a mechanically sound platform for treatment and rehabilitation. Frailty, operative risk, anticoagulant use, cardiopulmonary disease and personal priorities should influence whether surgery precedes radiation.
Spinal hardware and surgical wounds alter the risks of postoperative radiotherapy. Metal can create artefacts on planning scans, and radiation may affect wound healing or increase the risk of non-union or infection in some settings. With coordination between surgeon, radiation oncologist and physicist, treatment can often proceed safely. Timing should reflect clinical priority and fixation stability rather than a rigid calendar.
Timing radiotherapy alongside systemic therapy
Radiotherapy after surgery is used when residual tumour, involved margins or a high risk of local recurrence justifies additional treatment. Its rationale differs from treatment for an untouched metastasis, and the field must account for operative anatomy. A postoperative course is not mandatory for every stabilised spine. When margins are clear and local control appears satisfactory, observation with close review may be reasonable.
Systemic therapy remains essential because radiation treats a local site, not widespread metastatic disease. Medical oncologists balance radiation, systemic treatment and sequencing according to tumour subtype, response elsewhere and toxicity. Some combinations can be given together; others require separation. Clinical trials may offer additional information, although availability for spinal metastases varies between Australian centres.
Retreatment needs a separate risk-benefit discussion. Cord tolerance is finite, prior dose distribution matters, and vertebral weakening can follow high-dose treatment. A new neurological deficit may indicate recurrence, fracture, instability or treatment-related change rather than simple tumour regrowth. Prompt imaging and review are more useful than assuming the original plan remains appropriate.
Radiotherapy through an Australian lens
Australia's health system has public and private pathways for radiotherapy. Public patients generally access specialist treatment through Medicare-funded public hospital services and multidisciplinary referrals, while private patients may attend a radiation-oncology clinic through a general-practice referral. Medicare rebates and private insurance can cover part of the charges, but waiting times, out-of-pocket costs and treatment frequency can influence practical choices.
Complex cases concentrate around tertiary centres in Melbourne, Sydney, Brisbane and Perth, where neurosurgery, radiation oncology, pathology and rehabilitation can be accessed in one network. People living in regional, rural or remote areas may travel to Adelaide, Cairns, Darwin or a capital city for assessment, with some treatment delivered closer to home. Telehealth supports planning and follow-up, yet cannot remove the need to travel for imaging or irradiation.
Access also depends on cultural safety and communication. Aboriginal and Torres Strait Islander liaison services, clinically appropriate interpreters and respectful involvement of family or community representatives can support shared decisions without assuming what any individual wants. Hospital social workers can help arrange accommodation, travel assistance and respite care. A written care plan should identify who coordinates steroids, analgesia, appointments, transport and urgent contact.
Choosing treatment around the person's life
Patient-centred care means asking what a good outcome would look like: walking to the toilet, transferring safely, managing pain at home, caring for grandchildren or having time for family. Neurological recovery, pain relief and treatment burden are related, yet they are not interchangeable. Preserving comfort and function may suit one person better than a more intensive approach with a narrow chance of improvement.
Prognostic estimates need careful explanation. An individual course remains uncertain; what is the average provides context only when the population and endpoint behind the figure are understood. Age alone is a poor guide. Performance status, tumour biology, neurological function, comorbidity and treatment response often explain more, while advance care planning anchors the discussion in values.
Palliative-care involvement can run alongside active cancer treatment and should signal support rather than abandonment. Rehabilitation with physiotherapy and occupational therapy begins early, addressing strength, balance, transfers and equipment needs. Psychological support and practical wellbeing guidance may help patients and families manage fear, fatigue and uncertainty. Care goals can be reviewed as the person responds, declines or develops complications, without making the first decision permanent.
Common pathways compared
Common pathways emerge from the clinical pattern rather than the calendar. A stable painful metastasis may be managed with radiotherapy alone. Cord compression with an unstable spine may need urgent decompression and fixation. A previously irradiated lesion may need renewed imaging and a different balance of options. The aim is to match intervention to the threat without adding avoidable burden.
Follow-up should assess symptoms and function as carefully as imaging. I ask about pain, weakness, walking ability, continence, new mechanical symptoms and the effect of treatment on daily life. Improvement after radiotherapy may take weeks, whereas sudden deterioration needs urgent assessment. A new fracture or loss of fixation can require another surgical opinion, even when cancer is controlled elsewhere.
| Clinical situation | Surgical role | Radiotherapy role | Main trade-off |
|---|---|---|---|
| Stable painful vertebral metastasis | Usually no urgent surgery | Palliative external beam treatment | Prognosis versus treatment burden |
| Cord compression with a stable spine | Not routinely required | Prompt definitive treatment | Chance of neurological recovery |
| Cord compression with instability | Decompression and fixation may come first | Postoperative local control | Operative risk versus nerve preservation |
| Selected oligometastatic lesion | Biopsy or fixation only if indicated | Stereotactic body radiotherapy | High-dose precision versus limited evidence |
| Recurrent symptoms after prior radiation | Reassess instability and deficit | Selected re-irradiation | Cord tolerance and remaining goals |
This comparison is a discussion aid rather than an algorithm. The same tumour can move between pathways as pain changes, imaging evolves or priorities shift. Any plan should name the expected benefit, main risks, treatment burden and the point at which reassessment will occur. Outside the clinic, practical wellbeing ideas can complement physiotherapy, pain management and psychological support.
If you or someone you care for develops new weakness, numbness or bladder and bowel changes alongside a history of cancer, seek urgent medical assessment instead of waiting for a routine appointment. Ask for a coordinated review by a spinal oncology team, with a radiation oncologist and surgeon involved when the spine is unstable or the cord is compressed.
Readers who want to keep learning can follow Thamburaj for clinical insights, subscribe for updates, browse the curated e-library and join the open peer discussion forum. Contributing real decision points and outcomes can turn individual experience into shared learning, with the aim of better decisions, fewer avoidable complications and more time at home for the people we serve.